tiprankstipranks
Valneva (VALN)
NASDAQ:VALN
US Market
VALN
Valneva
RESEARCH TOOLSreports
Want to see VALN full AI Analyst Report?

Valneva (VALN) Stock News & Sentiment

344 Followers
Valneva Sets May 13 Date to Present First-Quarter 2026 Results
Premium
Company Announcements
Valneva Sets May 13 Date to Present First-Quarter 2026 Results
2d ago
6K
VALN
Valneva Raises Up to €84 Million via Private Placement Tied to Lyme Vaccine Milestone
Premium
Company Announcements
Valneva Raises Up to €84 Million via Private Placement Tied to Lyme Vaccine Milestone
6d ago
6K
VALN
Valneva Showcases Chikungunya Vaccine Progress at World Vaccine Congress in Washington
Premium
Company Announcements
Valneva Showcases Chikungunya Vaccine Progress at World Vaccine Congress in Washington
1M ago
6K
VALN
Valneva and Pfizer Report Strong Phase 3 Efficacy for Lyme Disease Vaccine Candidate
Premium
Company Announcements
Valneva and Pfizer Report Strong Phase 3 Efficacy for Lyme Disease Vaccine Candidate
1M ago
6K
VALN
Pfizer’s (PFE) Lyme Vaccine Partner Valneva Stock Crashes 38% despite Trial Success
Premium
Market News
Pfizer’s (PFE) Lyme Vaccine Partner Valneva Stock Crashes 38% despite Trial Success
1M ago
PFE
VALN
Valneva Posts 2025 Results, Flags 2026 as Pivotal Year Ahead of Lyme Vaccine Phase 3 Data
Premium
Company Announcements
Valneva Posts 2025 Results, Flags 2026 as Pivotal Year Ahead of Lyme Vaccine Phase 3 Data
2M ago
6K
VALN
VALN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
VALN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
VALN
More VALN News >

VALN News on the Web

Valneva price target lowered to $11 from $13 at Guggenheim
TipRanks News
Bullish
Weekly Buzz: CORT Wins FDA Nod In Cancer; MRK Acquires TERN; INSM Meets Trial Goals But VALN Misses
rttnews
Bearish
Valneva Showcases Chikungunya Vaccine Progress at World Vaccine Congress in Washington
TipRanks News
Neutral
VALN Stock Nosedives on Mixed Results From Lyme Disease Vaccine Study
Zacks
Bearish
Market Today: Stocks Rebound as Tesla Unveils $20B Terafab; Energy, Pharma, Crypto Move
GuruFocus News
Neutral
Valneva and Pfizer Report Strong Phase 3 Efficacy for Lyme Disease Vaccine Candidate
TipRanks News
Neutral
Jefferies says Valneva stock weakness presents buying opportunity
TipRanks News
Bullish
Valneva Plunges As Lyme Vaccine Misses Key Goal In Phase 3 Trial; Shows More Than 70% Efficacy
rttnews
Bearish

News Score - Last 7 Days

Neutral
VALN
Sector Average
Media Buzz
This Week1 articles
Weekly Average5.5 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VALN’s Media Buzz Sentiment?
1 articles about VALN were published this week. In an average week, 5.5 articles are published.
    What is VALN’s weekly average amount of articles?
    In an average week, 5.5 articles about VALN are published.
      What is VALN’s News Sentiment?
      100% of articles about VALN were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week